Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: A randomised, double-blind study

Lancet

Volumn 356, Issue 9245, 2000, Pages 1888-1894

  Høgh, Birthe ^a   Clarke, Paul D ^b   Camus, Daniel ^c   Nothdurft, Hans Dieter ^d   Overbosch, David ^e   Günther, Matthias ^f   Joubert, Izak ^g   Kain, Kevin C ^h   Shaw, Dea ^d,i   Roskell, Neil S ^d,i   Chulay, Jeffrey D ^d,i  

^a International Travel Vaccination Centre   (Denmark)

^b Med Advsy Serv Travellers Abroad   (United Kingdom)

^c INSTITUT PASTEUR DE LILLE   (France)

^d Department for Infectious Diseases and Tropical Medicine ^*

^e Harbour Hospital   (Netherlands)

^f Institute of Tropical Medicine   (Germany)

^g Travelsafe Clinic   (South Africa)

^h TORONTO GENERAL HOSPITAL   (Canada)

ⁱ GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; PROGUANIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRAVEL; TREATMENT OUTCOME;

EID: 0034597921     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03260-8     Document Type: Article

References (31)

1. Imported malaria (1985-95) trends and perspectives
2. Malaria surveillance-United States, 1995
3. Imported malaria prospective analysis of problems in diagnosis and management
4. Update on prevention of malaria for travellers
5. Neuropsychiatric adverse effects of mefloquine. What do we know and what should we do?
6. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis postal and telephone survey of travellers
7. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa
8. Efficacy and safety of atovaquone/proguanil for suppressive prophylaxis against Plasmodium falciparum malaria
9. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children
10. A randomized, double-blind, placebo-controlled field real to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia
11. Atovaquone and proguanil hydrochloride for prophylaxis of malaria
12. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine
13. Indirect fluorescent-antibody tests for parasitic diseases V. An evaluation of a thick-smear antigen in the IFA test for malaria antibodies
14. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction
15. Several allelles of the multidrug-resistance gene are closely linked to chloroquine resistance an Plasmodium falciparum
16. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
17. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine
18. Mutations in the Plasmodium falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
19. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance
20. Trials to assess equivalence the importance of rigorous methods
21. Adverse effects of antimalarials an update
22. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa
23. Antimalarial prophylaxis-use and adverse events in visitors to the Kruger National Park
24. Development of immunity in natural Plasmodium falciparum malaria antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32)
25. Malaria anticircumsporozoite antibodies in Dutch soldiers returning from sub-Saharan Africa
26. Malarone (atovaquone and proguanil hydrochloride), a review of its clinical development for treatment of malaria
27. Researches on paludrine (M 4888) in malaria. An experimental investigation undertaken by the L H Q Medical Research Unit (A I F), Cairns, Australia
28. Prophylactic activity of atovaquone against Plasmodium falciparum in humans
29. Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand